 Board of Directors Strengthens Its Independence Oversight and Updates its Stock Options VANCOUVER, BC ACCESSWIRE June 15, 2021 RepliCel Life Sciences Inc. OTCQB:REPCFTSXV:RPFRA:P6P2, RepliCel or the Company, a company developing next-generation technologies in aesthetics and orthopedics, is pleased to announce it has appointed Gary Boddington to the board of directors. Gary Boddington is currently the CEO of PlayWize Technology Inc. He is experienced in founding and leading global companies, exploring new markets, launching new products, and raising capital. 